PERIRENAL HEMATOMA AFTER URETEROSCOPY : A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.53555/nnmhs.v9i4.1648Keywords:
Bleeding, Perirenal Hematoma, Ureteroscopy, Renal, UrolithiasisAbstract
The global incidence of urolithiasis is 14%, and the burden of urological consultants has increased by 20% over the past seven years, according to current trends. As a consequence, stone disease is becoming a burden on our health care system. However, advancements in apparatus and technology over the past two decades have made it possible for endourologists to perform increasingly complex treatments for the management of stones. Endourologists who treat ureteral or renal calculi are required to be aware of PRH risk factors. PRH occurred more frequently among patients with a low BMI. Patients with a low BMI had less body fat and perirenal fat than those with a higher BMI. After an injury, perirenal fat cushions the kidney to prevent cortical overstretching caused by an increase in renal pelvis irrigation pressure. PRH is produced in kidneys with minimal perirenal adipose. Two of the four patients with PRH had a low BMI. Underweight can be a sign of malnutrition, which can impair the structure of the kidneys. The timing of surgery is uncertain. PRH caused by FURSL may be treated as a kidney injury. If the patient has loin or flank pain after FURSL, the surgeon should examine the serum hemoglobin and perform abdominal sonography or a CT scan to detect PRH. Hematomas with mass effect were evacuated percutaneously when they were large. Percutaneous drainage may delay the progression of a hematoma in stable patients, although it may cause severe discomfort or renal compression. Angiograms should be used to treat renal bleeding if the serum hemoglobin continues to decline. If conservative or angiographic therapy fails to control bleeding, immediate open surgery must be performed. Cases of PRH are extremely uncommon, with percentages ranging from 0.1 to 8.9%. Despite this, this condition needs to be monitored closely because it has the potential to compromise the patient's health in a negative way.
References
Rukin NJ, Siddiqui ZA, Chedgy ECP, Somani BK. Trends in upper tract stone disease in England: evidence from the hospital episodes statistics database. Urol Int. 2017;98(4):391–6.
Hsu C-S, Wang C-J, Chang C-H, Tsai P-C, Chen H-W, Su Y-C. Emergency percutaneous nephrostomy versus emergency percutaneous nephrolithotomy in patients with sepsis associated with large uretero-pelvic junction stone impaction: a randomized controlled trial. Int braz j urol. 2017;43:481–8.
Pietropaolo A, Proietti S, Geraghty R, Skolarikos A, Papatsoris A, Liatsikos E, et al. Trends of ‘urolithiasis: interventions, simulation, and laser technology’over the last 16 years (2000–2015) as published in the literature (PubMed): a systematic review from European section of Uro-technology (ESUT). World J Urol. 2017;35:1651–8.
Jung H, Andonian S, Assimos D, Averch T, Geavlete P, Kohjimoto Y, et al. Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease. World J Urol. 2017;35:1331–40.
Somani BK, Giusti G, Sun Y, Osther PJ, Frank M, De Sio M, et al. Complications associated with ureterorenoscopy (URS) related to treatment of urolithiasis: the Clinical Research Office of Endourological Society URS Global study. World J Urol. 2017;35:675–81.
Muslumanoglu AY, Fuglsig S, Frattini A, Labate G, Nadler RB, Martov A, et al. Risks and benefits of postoperative double-J stent placement after ureteroscopy: results from the Clinical Research Office of Endourological Society Ureteroscopy Global Study. J Endourol. 2017;31(5):446–51.
De La Rosette J, Denstedt J, Geavlete P, Keeley F, Matsuda T, Pearle M, et al. The clinical research office of the endourological society ureteroscopy global study: indications, complications, and outcomes in 11,885 patients. J Endourol. 2014;28(2):131–9.
Bansal U, Sawant A, Dhabalia J. Subcapsular renal hematoma after ureterorenoscopy: an unknown complication of a known procedure. Urol Ann. 2010;2(3):119.
Whitehurst LA, Somani BK. Perirenal hematoma after ureteroscopy: a systematic review. J Endourol. 2017;31(5):438–45.
Sabler IM, Katafygiotis I, Duvdevani M. Postoperative Care of the Ureteroscopy. Ureteroscopy A Compr Contemp Guid. 2019;141.
Ilic P, Djordjevic M, Kojovic V, Dzambasanovic S. Laser lithotripsy in the treatment of renal stones in children. A single-center experience. Ann Ital Chir. 2016;87:326–32.
Kao M-H, Wang C-C. Risk factors for developing a perirenal hematoma after flexible ureteroscopic lithotripsy. Urol Sci [Internet]. 2016;27(3):166–70. Available from: https://www.sciencedirect.com/science/article/pii/S1879522615004297
Talwar HS, Panwar VK, Narain TA, Mittal A, Ranjan R. Subcapsular Renal Hematoma Following Ureteroscopic Lithotripsy: An Uncommon Complication of a Common Procedure—A Report of Two Cases. J Endourol Case Reports. 2020;6(3):244–7.
Tao W, Cai CJ, Sun CY, Xue BX, Shan YX. Subcapsular renal hematoma after ureteroscopy with holmium:yttrium-aluminum-garnet laser lithotripsy. Lasers Med Sci. 2015 Jul;30(5):1527–32.
Yu J, Li B, Ren BX, Zhang NY, Jin BX, Zhang JJ. Subcapsular renal haematoma after ureteroscopic lithotripsy: a single-centre, retrospective study in China. BMJ Open. 2022 Nov;12(11):e062866.
Bai J, Li C, Wang S, Liu J, Ye Z, Yu X, et al. Subcapsular renal haematoma after holmium:yttrium-aluminum-garnet laser ureterolithotripsy. BJU Int. 2012 Apr;109(8):1230–4.
Chiu PK-F, Chan C-K, Ma W, To K-C, Cheung F-K, Yiu M. Subcapsular hematoma after ureteroscopy and laser lithotripsy. J Endourol. 2013;27(9):1115–9.
Anan G. Editorial Comment from Dr Anan to subcapsular renal hematoma after ureterorenoscopy. IJU Case Reports. 2022;5(4):286–7.
Beland MD, Walle NL, Machan JT, Cronan JJ. Renal cortical thickness measured at ultrasound: is it better than renal length as an indicator of renal function in chronic kidney disease? Am J Roentgenol. 2010;195(2):W146–9.
Yuruk E, Binbay M, Ozgor F, Erbin A, Berberoglu Y, Muslumanoglu AY. Flexible ureterorenoscopy is safe and efficient for the treatment of kidney stones in patients with chronic kidney disease. Urology. 2014;84(6):1279–84.
Lin S-Y, Lin C-L, Chang C-H, Wu H-C, Chen W-C, Wang I-K, et al. Comparative risk of chronic kidney diseases in patients with urolithiasis and urological interventions: a longitudinal population-based study. Urolithiasis. 2017;45(5):465–72.
Mitsogiannis IC, Kostakopoulos NA, Lazarou L, Deliveliotis K, Karagiotis T, Deliveliotis C. Renal Hematomas After Ureterolithotripsy: Report of Four Cases. J Endourol Case Reports [Internet]. 2019 Sep 12;6(1):26–9. Available from: https://doi.org/10.1089/cren.2019.0103
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Journal of Advance Research in Medical & Health Science (ISSN: 2208-2425)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
